Replimune Group
Develops RPx oncolytic immunotherapies for melanoma and other solid tumors.
Something off on this page? Send us feedback.
Breakdown13F · Form 4
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 84.03M · Float —
Float — provider float is below the insider stake.
The provider's float is smaller than the insider stake it should exclude, so it is not shown.
Institutions13F, as of Jun 30, 2026
226 holders · 96.10M shares · 75 new positions · 148 increased · 46 reduced · 57 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 11.05M | 13.15% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 8.96M | 10.66% | +2.72M | Aug 7, 2026 |
| RTW Investments, LP | 7.41M | 8.82% | +54.7K | Aug 14, 2026 |
| Ridgeback Capital Investments L.P. | 7.31M | 8.70% | +7.31Mnew | Aug 14, 2026 |
| Goldman Sachs Group Inc | 4.54M | 5.40% | +2.26M | Aug 14, 2026 |
| State Street Corp | 4.44M | 5.28% | +657.9K | Aug 7, 2026 |
| Suvretta Capital Management, LLC | 4.39M | 5.22% | +168.0K | Aug 14, 2026 |
| Boxer Capital Management, LLC | 3.98M | 4.74% | +2.81M | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLCincl. Felix J. Baker, Baker Bros. Advisors LP +1 more | 11.80% | 11.08M | 13D | Aug 11, 2026 ↗ |
| RTW Investments, LP | 8.90% | 7.36M | 13G | May 15, 2026 ↗ |
| Ridgeback Capital Investments L.P. | 7.60% | 6.25M | 13G | May 21, 2026 ↗ |
| The Goldman Sachs Group, Inc. | 5.30% | 4.42M | 13G | Aug 10, 2026 ↗ |
| State Street Corporation | 5.30% | 4.44M | 13G | Aug 7, 2026 ↗ |
| Suvretta Capital Management, LLC | 5.10% | 4.22M | 13G | May 12, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | director, 10 percent owner: | 10.12M | 12.04% | Mar 7, 2025 |
| Philip Astley-Sparke | director | 1.36M | 1.62% | Aug 24, 2026 |
| Sushil Patel | director, officer: Chief Executive Officer | 708.2K | 0.84% | Aug 12, 2026 |
| Konstantinos Xynos | officer: Chief Medical Officer | 224.2K | 0.27% | Aug 12, 2026 |
| Emily Luisa Hill | officer: Chief Financial Officer | 215.9K | 0.26% | Aug 19, 2026 |
| Christopher Sarchi | officer: Chief Commercial Officer | 181.0K | 0.22% | Jun 3, 2026 |
| Andrew Schwendenman | officer: Chief Accounting Officer | 99.4K | 0.12% | Aug 12, 2026 |
5 ten-percent owners hold 7.70M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 12 people have not refiled in the last 18 months (14.59M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | Emily Luisa Hillofficer: Chief Financial Officer | Sale | 9,256 | $14.28 | 215,852 |
| Aug 10, 2026 | Andrew Schwendenmanofficer: Chief Accounting Officer | Sale | 7,632 | $12.97 | 99,425 |
| Aug 10, 2026 | Konstantinos Xynosofficer: Chief Medical Officer | Sale | 11,447 | $12.97 | 224,215 |
| Aug 10, 2026 | Emily Luisa Hillofficer: Chief Financial Officer | Sale | 11,448 | $12.97 | 225,108 |
| Aug 10, 2026 | Sushil Pateldirector, officer: Chief Executive Officer | Sale | 39,341 | $12.97 | 708,151 |
| Aug 11, 2026 | Baker Bros. Advisors LPdirector, 10 percent owner: | Purchase · 2 lots | 2,736,340 | $0.0001 | 2,609,946 |
| Jun 1, 2026 | Christopher Sarchiofficer: Chief Commercial Officer | Sale | 12,000 | $9.24 | 180,962 |
| May 18, 2026 | Emily Luisa Hillofficer: Chief Financial Officer | Sale | 7,812 | $5.08 | 236,556 |
| May 18, 2026 | Sushil Pateldirector, officer: Chief Executive Officer | Sale | 37,324 | $5.08 | 747,492 |
| May 18, 2026 | Philip Astley-Sparkedirector | Sale | 17,657 | $5.08 | 1,412,414 |
CongressHouse and Senate disclosures
Not reported.